Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors  at ASCO Annual Meeting
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery